Umbra Applied Technologies Group Inc (UATG)

[helpx]

Alex scam shareholders 2014

Chairman of Umbra Applied Technologies Group, Alex Umbra, remarked that “We are truly excited about the future of Propestat and look forward to undergoing preclinical trials in the near future”. Propestat was developed under exclusive agreement with Protokinetix (OTC:PKTX). Umbra Applied Technologies Group anticipates that its continued collaboration with Protokinetix will ensure that Propestat impacts the biotechnology community, and ultimately, patients in a very meaningful way.”
About Intrepid Innovations Corporation